We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
OFIX icon
601
CALL
Orthofix Medical
OFIX
$374M
– –
-50,000
Closed -$37.5K –
ORCL icon
602
Oracle
ORCL
$429B
– –
-52,486
Closed -$6.59M –
ORIC icon
603
CALL
Oric Pharmaceuticals
ORIC
$1.24B
– –
-80,000
Closed -$50K –
PANW icon
604
Palo Alto Networks
PANW
$343B
– –
-2,800
Closed -$398K –
PATH icon
605
UiPath
PATH
$7.03B
– –
-50,000
Closed -$1.13M –
PHAT icon
606
Phathom Pharmaceuticals
PHAT
$587M
– –
-28,583
Closed -$304K –
PLTR icon
607
Palantir
PLTR
$502B
– –
-10,000
Closed -$230K –
PMVP icon
608
PMV Pharmaceuticals
PMVP
$81.3M
– –
-56,852
Closed -$96.6K –
PRAX icon
609
CALL
Praxis Precision Medicines
PRAX
$7.26B
– –
-27,100
Closed -$238K –
PRCT icon
610
Procept Biorobotics
PRCT
$1.05B
– –
-13,217
Closed -$653K –
PTCT icon
611
CALL
PTC Therapeutics
PTCT
$5.4B
– –
-20,000
Closed -$44.5K –
QTRX icon
612
Quanterix
QTRX
$155M
– –
-16,794
Closed -$396K –
RAPT icon
613
DELISTED
RAPT Therapeutics
RAPT
– –
-9,136
Closed -$422K –
RDN icon
614
PUT
Radian Group
RDN
$4.49B
– –
-59,000
Closed -$22.8K –
RLAY icon
615
Relay Therapeutics
RLAY
$3.92B
– –
-100,039
Closed -$830K –
SNDX icon
616
CALL
Syndax Pharmaceuticals
SNDX
$1.52B
– –
-77,400
Closed -$44.9K –
SRRK icon
617
Scholar Rock
SRRK
$5.14B
– –
-41,378
Closed -$735K –
STX icon
618
Seagate
STX
$178B
– –
-17,500
Closed -$1.63M –
TAL icon
619
TAL Education Group
TAL
$7.13B
– –
-312,000
Closed -$3.54M –
TRML icon
620
PUT
DELISTED
Tourmaline Bio
TRML
– –
-20,000
Closed -$345K –
TSLA icon
621
PUT
Tesla
TSLA
$1.51T
– –
-50,000
Closed -$170K –
TTD icon
622
Trade Desk
TTD
$5.71B
– –
-11,000
Closed -$962K –
TV icon
623
CALL
Televisa
TV
$1.16B
– –
-73,500
Closed -$132K –
VERA icon
624
CALL
Vera Therapeutics
VERA
$2.15B
– –
-20,000
Closed -$97K –
VNET icon
625
VNET Group
VNET
$1.57B
– –
-150,000
Closed -$233K –
23 24
25
26 27

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.